Figure 4.
Lower ferroportin levels but higher ferroportin activity in PCBP1ΔIEC mice. (A) Lower levels of ferroportin on duodenal epithelium of PCBP1ΔIEC vs WT mice. Fluorescent immunohistochemistry for FPN in proximal duodenum from 2 months old mice. DAPI (4′,6-diamidino-2-phenylindole) stain indicates nuclei. Representative images on the left show quantitative analysis of fluorescence at right. (B) Lower levels of ferroportin in IECs of PCBP1ΔIEC vs WT mice. IECs from 2 months mice analyzed for FPN and DMT1 by immunoblot. Representative blot on the left, quantitation on the right. (C) Intact tight junctions in intestinal epithelium of PCBP1ΔIEC mice. Mice were administered FITC-dextran (4000 MW) through oral gavage. IECs and plasma were collected after 1 hour and FITC-dextran measured. (D) Higher levels of hepcidin mRNA in livers of PCBP1ΔIEC vs WT mice. Hepcidin mRNA levels in liver were measured by qPCR in 2 months mice. (E) Higher levels of hepcidin mRNA in livers of PCBP1ΔIEC mice on a high-iron diet. Mice were fed defined-iron diets for 1 month and liver hepcidin mRNA levels were analyzed. (F) Ferroportin mediates excess iron absorption through intestinal epithelium of PCBP1ΔIEC mice. Mice were injected intraperitoneally with synthetic hepcidin or vehicle followed by oral gavage with 57Fe solution. IECs, plasma, and liver samples were collected after 1 hour and 57Fe levels measured.